PatternsRadar
Sign in

AUROPHARMAAurobindo Pharma Limited

NSEF&O
1,799.00INR-6.70 (-0.37%)Close · 20 Nov 2026
4 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1.04L CrMarket cap
25.9P/E (TTM)
61.6%Delivery

Filings & corporate actions

78 results filed
CSV
Next results · Q3 FY27
Expected 6 Feb 2027 – 10 Feb 2027
Estimate: filed 37–41 days after quarter end, last 5 times
Dividend
₹7.00 per share · last 11 Nov 2026
2026
  • 11 NovdividendDividend · ₹7.00 per share · record 11 Nov 2026-1.5%
  • 4 NovresultsResults · Q2 FY27 · consolidated and standalone+4.7%NSE
  • 14 OctshareholdingShareholding · 30 Sept 2026-1.3%NSE
  • 5 AugresultsResults · Q1 FY27 · consolidated and standalone-1.5%NSE
  • 15 JulshareholdingShareholding · 30 Jun 2026-0.2%NSE
  • 21 MayresultsResults · Q4 FY26 · consolidated and standalone-5.4%NSE
  • 17 AprshareholdingShareholding · 31 Mar 20260.0%NSE
  • 17 AprbuybackBuy Back0.0%
  • 9 FebresultsResults · Q3 FY26 · consolidated and standalone-6.6%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025-0.4%NSE

Reaction to results · all yearsrose on day 0 in 38 of 77 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY274 Nov 2026+4.7%+6.0%—3.5×
Q1 FY275 Aug 2026-1.5%+3.1%+1.5%1.4×
Q4 FY2621 May 2026-5.4%-7.3%-3.5%2.4×
Q3 FY269 Feb 2026-6.6%-1.4%+8.4%6.9×
Q2 FY265 Nov 2025-0.7%+5.3%+6.4%1.0×
Q1 FY264 Aug 2025-1.0%-3.0%-5.0%2.4×
Q4 FY2527 May 2025+0.9%-3.1%-6.5%2.4×
Q3 FY256 Feb 20250.0%-5.1%-8.3%1.4×
Q2 FY259 Nov 2024-2.9%-5.8%-7.7%4.1×
Q1 FY2510 Aug 2024+0.8%+6.0%+4.7%1.6×
Q4 FY2425 May 2024-3.1%-0.6%-1.4%2.9×
Q3 FY2410 Feb 2024+1.5%+3.8%+6.1%2.1×
Q2 FY2410 Nov 2023+3.0%+6.0%+5.6%3.0×
Q1 FY2412 Aug 2023+1.0%-2.4%+0.9%1.7×
Q4 FY2327 May 2023-0.6%+7.2%+17.3%3.1×
Q3 FY2310 Feb 2023+6.3%+7.3%+1.7%6.3×
Q2 FY2312 Nov 2022-0.4%-5.2%-7.8%4.6×
Q1 FY2312 Aug 2022+3.1%-4.2%-3.9%5.2×
Q4 FY2231 May 2022+1.9%-1.5%-3.1%1.9×
Q3 FY2210 Feb 2022+4.3%+2.8%-2.1%3.8×
Q2 FY229 Nov 2021+0.7%+2.2%+4.5%5.7×
Q1 FY2212 Aug 2021-7.9%-17.3%-9.5%13.4×
Q4 FY2131 May 2021-2.8%-2.6%-3.1%2.0×
Q3 FY2111 Feb 2021-3.4%-5.8%-12.4%1.7×
Q2 FY2112 Nov 2020+3.5%+2.8%+9.7%5.3×
Q1 FY2113 Aug 2020-5.7%-8.2%-14.1%2.6×
Q4 FY204 Jun 2020+1.2%+4.7%+3.9%3.0×
Q3 FY207 Feb 2020+7.1%+0.8%-7.7%5.1×
Q2 FY2013 Nov 2019-8.8%-1.0%+3.4%3.9×
Q1 FY208 Aug 2019+7.8%+8.9%+13.3%4.7×
Q4 FY1919 Jun 2019+2.4%0.0%-6.9%0.4×
Q3 FY1920 Feb 2019+2.1%+1.6%+8.5%1.0×
Q2 FY1926 Nov 2018+0.8%+1.9%-9.4%0.6×
Q1 FY1924 Aug 2018+1.6%+4.4%+11.4%1.3×
Q4 FY1826 Jun 2018+1.4%+2.9%-3.6%1.1×
Q3 FY1813 Mar 2018-0.2%-1.9%+5.0%0.7×
Q2 FY1811 Nov 2017-4.0%-4.5%-6.7%2.2×
Q1 FY1818 Aug 2017-1.2%+3.7%+6.3%0.6×
Q4 FY176 Jun 2017+2.2%+2.9%+16.8%0.7×
Q3 FY1711 Feb 2017-2.6%-1.5%-0.2%1.7×
Q2 FY1725 Nov 2016-0.5%-2.2%-15.7%0.7×
Q1 FY1729 Sept 2016+3.7%+3.7%-2.0%1.1×
Q4 FY1631 May 2016+4.1%+2.2%-3.2%2.6×
Q3 FY1611 Feb 2016+3.6%+2.6%+15.2%2.4×
Q2 FY167 Nov 2015+5.2%+2.1%-3.4%1.4×
Q1 FY1616 Aug 2015+2.8%-6.3%-6.4%1.2×
Q4 FY151 Jun 2015-1.0%-5.9%+2.1%0.5×
Q3 FY157 Feb 2015-5.5%-0.5%+1.7%1.7×
Q2 FY1511 Nov 2014+0.8%+11.8%+10.6%0.8×
Q1 FY1512 Aug 2014-0.8%+5.4%+16.7%0.9×
Q4 FY142 Jul 2014+2.5%-7.4%-2.7%1.1×
Q3 FY147 Feb 2014+2.8%-0.7%+2.9%2.1×
Q2 FY1422 Nov 2013+1.2%+6.7%+37.3%0.6×
Q1 FY1416 Aug 2013-1.3%-1.8%-4.6%0.8×
Q4 FY133 Jul 2013-0.6%+3.1%-8.9%0.6×
Q3 FY138 Feb 2013-1.5%-1.0%-11.6%1.5×
Q2 FY139 Nov 2012-4.7%-2.1%+7.2%2.8×
Q1 FY138 Aug 2012-1.7%-7.1%+10.1%3.4×
Q4 FY1230 May 2012-2.0%-1.1%-2.4%1.2×
Q3 FY1214 Feb 2012+7.9%+4.1%+7.1%2.5×
Q2 FY128 Nov 2011-3.4%-30.8%-27.0%5.1×
Q1 FY128 Aug 2011-3.0%-10.2%-16.1%1.2×
Q3 FY115 Feb 2011-1.4%-0.6%-21.0%2.3×
Q2 FY113 Nov 2010+1.8%+6.3%+4.3%5.6×
Q1 FY115 Aug 2010-4.4%-2.7%+6.3%3.0×
Q3 FY1030 Jan 2010+5.8%+4.3%+9.5%1.5×
Q2 FY1030 Oct 20090.0%+6.6%+15.0%1.1×
Q1 FY1031 Jul 2009+3.7%+6.5%+23.8%1.4×
Q4 FY0930 Apr 2009+10.3%+36.2%+80.5%2.5×
Q3 FY0930 Jan 2009-6.3%-11.3%-2.2%2.3×
Q2 FY0931 Oct 2008+4.0%+7.6%-11.6%3.0×
Q1 FY0930 Jul 2008+0.2%+8.7%+11.2%1.2×
Q4 FY0818 Jun 2008-5.0%-17.1%-20.6%3.4×
Q3 FY0830 Jan 2008-12.3%-18.2%-17.9%0.7×
Q2 FY0831 Oct 2007+2.0%-5.4%-14.5%1.4×
Q1 FY0831 Jul 2007-1.6%-4.9%-9.4%1.5×
Q4 FY071 Jul 2007-2.8%-8.0%-18.3%1.5×
Average+0.0%-0.3%+0.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+23.9%
Profit YoY+32.7%
Interest cost YoY-7.4%
Revenue QoQ+12.2%
Profit QoQ+9.1%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+10.4%+11.1%+11.6%+9.0%+7.1%—
Profit+5.5%+19.7%+17.3%-5.2%+4.1%—

Key data

Open1,788.10
Day range1,788.10 – 1,817.50
52-week range1,106.00 – 1,859.90
From 52w high-3.3%
RSI (14)60.5
ATR (14)40.24
Volume8.11L
Avg volume (20D)12.88L
Rel volume0.63×
Volatility (1Y)26.4%
Turnover₹146.4Cr
Traded value (NSE)₹146.4Cr
VWAP1,804.42
SMA 50 / 2001,704.58 / 1,504.03
Price bandNo band
MWPL used38.0%

Delivery percentage

Latest · 20 Nov 202661.6%
20-day avg53.6%
1-year avg48.5%
Percentile (own history)98th
Range6.5–78.1%
Sessions3,629

Over the last 20 sessions AUROPHARMA settled 53.6% of its traded quantity, which is above average for an NSE equity. Its one-year average is 48.5%, so recent sessions are running 5.2 points higher than usual. The latest session ranks higher than 98% of the 3,629 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.39%
Dividend, trailing 12M₹7.00
Paid every year for1 yr
Shareholders2.34L · -2.2% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy4,445 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.37%-1.33%+11.68%+11.88%+16.31%+47.16%

Valuation

Market cap₹1.04L Cr
Market cap (NSE)₹1.04L Cr
Free-float cap₹49,809 Cr
P/E (TTM)25.9
P/E (NSE)26.1
EPS (TTM)69.35
P/B2.6
Net margin (TTM)10.8%
Other income / PBT12.6%
ROE10.7%
Debt / equity0.21
Shares outstanding57.54Cr
Listed19 Jul 2000

Ownership

Promoter51.88%
Promoter Δ QoQ0.00 pp
Public48.12%
FII17.41%
DII24.42%
Pledged11.99%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)8,645.98,853.39,150.410,263.3
YoY chg+8.4%+5.6%+16.3%+23.9%
Net profit (₹ Cr)909.8920.81,032.01,123.8
YoY chg+7.6%+2.0%+25.2%+32.5%
Net margin10.5%10.4%11.3%11.0%
EPS15.6715.8617.8619.57

Shareholding over time

By quarter

30 Sept 2026 · promoter 51.88% · public 48.12%
30 Sept 2021: promoter 51.83%31 Dec 2021: promoter 51.83%31 Mar 2022: promoter 51.83%30 Jun 2022: promoter 51.83%30 Sept 2022: promoter 51.83%31 Dec 2022: promoter 51.83%31 Mar 2023: promoter 51.83%30 Jun 2023: promoter 51.83%30 Sept 2023: promoter 51.83%31 Dec 2023: promoter 51.83%31 Mar 2024: promoter 51.83%30 Jun 2024: promoter 51.80%30 Sept 2024: promoter 51.82%31 Dec 2024: promoter 51.82%31 Mar 2025: promoter 51.82%30 Jun 2025: promoter 51.82%30 Sept 2025: promoter 51.82%31 Dec 2025: promoter 51.82%31 Mar 2026: promoter 51.82%30 Jun 2026: promoter 51.88%30 Sept 2026: promoter 51.88%
2021-092026-09
  • Promoter
  • Public and others
Promoter
51.88%
Public
48.12%
Promoter change
0.00 pp
Filed
14 Oct 2026
FII
17.41%
DII
24.42%
Promoter pledged
11.99%

Who the public is

Mutual funds
16.31%

-0.40 pp QoQ

Insurance
4.84%

-0.15 pp QoQ

FPI
17.41%

+1.03 pp QoQ

Retail ≤ ₹2L
4.69%

-0.34 pp QoQ

HNI > ₹2L
0.33%

0.00 pp QoQ

NRI
0.36%

-0.02 pp QoQ

Bodies corporate
0.59%

+0.10 pp QoQ

Shareholders
2,33,737

-2.2% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING)Promoter · Corporate33.54%
QUANT MUTUAL FUND - QUANT ARBITRAGE FUNDMutual fund4.91%
KAMBAM NITHYANANDA REDDYPromoter · Individual4.37%
SBI NIFTY MIDCAP 150 INDEX FUNDMutual fund3.51%
KIRTHI REDDY KAMBAMPromoter · Individual3.46%
HDFC MUTUAL FUND-HDFC ARBITRAGE FUNDMutual fund3.22%
VENKATA RAMPRASAD REDDY PENAKAPromoter · Individual3.07%
AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PVT.LTD. (JOINTLY HOLDING)Promoter · Corporate2.86%
LIFE INSURANCE CORPORATION OF INDIAInsurance2.85%
NPS TRUST A/C - SBI PENSION FUND - UPS - CG SCHEMPension / PF2.80%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 30 Jul 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹7.00₹7.00
FY2025-261₹4.00₹4.00
FY2023-242₹4.50₹4.50
FY2022-232₹7.50₹7.50
FY2021-223₹4.50₹4.50
FY2020-213₹4.00₹4.00
FY2019-202₹3.00₹3.00
FY2018-192₹2.50₹2.50
FY2017-183₹3.75₹3.75
FY2016-172₹1.95₹1.95
FY2015-164₹2.80₹2.30
FY2014-153₹5.25₹2.63
FY2013-142₹1.75₹0.88
FY2012-132₹2.00₹1.00
Ex-dateRecord dateDeclaredAdjusted
11 Nov 202611 Nov 2026₹7.00₹7.00
8 Aug 2025—₹4.00₹4.00
20 Feb 2024—₹1.50₹1.50
20 Nov 2023—₹3.00₹3.00
17 Feb 2023—₹3.00₹3.00
6 Jun 2022—₹4.50₹4.50
18 Feb 2022—₹1.50₹1.50
17 Nov 2021—₹1.50₹1.50
27 Aug 2021—₹1.50₹1.50
22 Feb 2021—₹1.50₹1.50
23 Nov 2020—₹1.25₹1.25
21 Aug 2020—₹1.25₹1.25
17 Feb 2020—₹1.75₹1.75
21 Nov 2019—₹1.25₹1.25
15 Feb 2019—₹1.25₹1.25
20 Nov 2018—₹1.25₹1.25
20 Feb 2018—₹1.00₹1.00
21 Nov 2017—₹1.50₹1.50
8 Jun 2017—₹1.25₹1.25
24 Nov 2016—₹1.25₹1.25
9 Jun 2016—₹0.70₹0.70
18 Feb 2016—₹0.70₹0.70
19 Nov 2015—₹0.60₹0.60
21 Aug 2015—₹0.50₹0.50
8 Jun 2015—₹1.00₹0.50
16 Feb 2015—₹2.00₹1.00
13 Aug 2014—₹1.50₹0.75
11 Jun 2014—₹1.75₹0.88
19 Nov 2013—₹1.25₹0.63
30 Jul 2013—₹0.50₹0.25
18 Feb 2013—₹1.00₹0.50
30 Jul 2012—₹1.00₹0.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
6.7 years ago
Disclosures on record
495
51 open-market of the newest 100
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
5 Mar 2024PAVANKUMAR PSEmployeeSell1.0K₹10.2L1,022.003.0K → 2.0K0.00%0.00 pp7(2)told 5 Mar 2024
1 Mar 2024CHANDRASEKHAR REDDY KANDATIEmployeeSell2.0K₹20.9L1,047.394.7K → 2.6K0.00%0.00 pp7(2)told 28 Feb 2024
23 Feb 2024PAVANKUMAR PSEmployeeSell1.0K₹10.3L1,025.004.0K → 3.0K0.00%0.00 pp7(2)told 22 Feb 2024
21 Feb 2024K NAGARAJUOtherSell5.0K₹52.4L1,048.4614.8K → 9.8K0.00%0.00 pp7(2)told 20 Feb 2024
21 Feb 2024Dr AMBATI RAMA MOHANA RAOEmployeeSell5.0K₹51.0L1,020.001.48L → 1.43L0.02%-0.00 pp7(2)told 20 Feb 2024
16 Feb 2024K BHARATHIOtherSell35.0K₹3.6Cr1,017.1135.5K → 4500.00%0.00 pp7(2)told 16 Feb 2024
16 Feb 2024GITA RAOEmployeeSell1.3K₹12.8L983.001.3K → —0.00%7(2)told 16 Feb 2024
16 Feb 2024S BALA SUBRAMANYAM REDDYEmployeeSell2.0K₹20.5L1,027.002.0K → —0.00%7(2)told 14 Feb 2024
16 Feb 2024ROOPAK SAWHNEYEmployeeSell3.9K₹39.2L1,011.098.4K → 4.5K0.00%0.00 pp7(2)told 16 Feb 2024
2 Jan 2024K R VIJAYAPAL REDDYEmployeeSell1.0K₹10.8L1,082.605.0K → 4.0K0.00%0.00 pp7(2)told 1 Jan 2024
29 Dec 2023S SADANANDA REDDYOtherSell15.0K₹1.6Cr1,071.612.55L → 2.40L0.04%-0.00 pp7(2)told 29 Dec 2023
29 Dec 2023S Bala Subramanyam ReddyEmployeeSell1.0K₹10.8L1,079.003.0K → 2.0K0.00%0.00 pp7(2)told 29 Dec 2023
29 Dec 2023P. SASHI KUMARANEmployeeSell9.0K₹97.2L1,080.0231.5K → 22.5K0.00%0.00 pp7(2)told 29 Dec 2023
29 Dec 2023Akkiraju Venkata Satya Murali MohanEmployeeSell4.0K₹43.1L1,077.5019.0K → 15.0K0.00%0.00 pp7(2)told 29 Dec 2023
27 Dec 2023GOUTAM SENEmployeeSell1.5K₹16.0L1,065.673.0K → 1.5K0.00%0.00 pp7(2)told 26 Dec 2023
27 Dec 2023Dr AMBATI RAMA MOHANA RAOEmployeeSell2.5K₹27.1L1,085.001.50L → 1.48L0.03%-0.00 pp7(2)told 27 Dec 2023
22 Dec 2023Jacob JosephOtherSell1.5K₹15.7L1,044.006.0K → 4.5K0.00%0.00 pp7(2)told 21 Dec 2023
22 Dec 2023SURYANARAYANA MURTHY MULAEmployeeSell3.5K₹37.4L1,067.997.5K → 4.0K0.00%0.00 pp7(2)told 21 Dec 2023
15 Dec 2023SAMUDRALA VL ROJA RANIRelativeSell1.0K₹10.1L1,014.001.4K → 4500.00%0.00 pp7(2)told 15 Dec 2023
6 Dec 2023S SADANANDA REDDYOtherSell3.0K₹31.2L1,040.502.58L → 2.55L0.04%-0.00 pp7(2)told 5 Dec 2023
1 Dec 2023BASAVA SANKARA RAO V NIMMAGADDAEmployeeSell1.4K₹13.8L1,022.402.7K → 1.4K0.00%0.00 pp7(2)told 1 Dec 2023
1 Dec 2023GITA RAOEmployeeSell1.0K₹10.3L1,030.382.3K → 1.3K0.00%0.00 pp7(2)told 29 Nov 2023
27 Nov 2023S SADANANDA REDDYOtherSell7.0K₹72.8L1,039.592.65L → 2.58L0.04%-0.00 pp7(2)told 24 Nov 2023
27 Nov 2023VENKATA NARAYANA REDDY JAYAMPUOtherSell6.0K₹62.1L1,034.007.4K → 1.4K0.00%0.00 pp7(2)told 24 Nov 2023
27 Nov 2023MAHESH BHASKAR SHINDEEmployeeSell1.6K₹16.5L1,031.885.6K → 4.0K0.00%0.00 pp7(2)told 24 Nov 2023
27 Nov 2023THOMAS KOSHY VEmployeeSell2.1K₹21.8L1,037.752.1K → —0.00%7(2)told 24 Nov 2023
22 Nov 2023T S SANKARA REDDYOtherSell2.0K₹20.2L1,011.147.3K → 5.3K0.00%0.00 pp7(2)told 22 Nov 2023
22 Nov 2023PRASHANT VITHAL KULKARNIEmployeeSell2.3K₹22.4L974.004.6K → 2.3K0.00%0.00 pp7(2)told 22 Nov 2023
21 Nov 2023VENKATA NARAYANA REDDY JAYAMPUOtherSell10.5K₹1.0Cr999.8017.9K → 7.4K0.00%0.00 pp7(2)told 20 Nov 2023
21 Nov 2023PAVANKUMAR PSEmployeeSell1.3K₹13.1L1,010.005.3K → 4.0K0.00%0.00 pp7(2)told 21 Nov 2023
10 Oct 2023Dr AMBATI RAMA MOHANA RAOEmployeeSell6.0K₹55.3L922.071.56L → 1.50L0.03%-0.00 pp7(2)told 10 Oct 2023
5 Oct 2023KANNAIAH GANDALAEmployeeSell1.1K₹10.0L913.001.1K → —0.00%7(2)told 4 Oct 2023
4 Oct 2023S.Sadananda ReddyOtherSell5.0K₹46.4L927.002.70L → 2.65L0.05%-0.00 pp7(2)told 4 Oct 2023
4 Oct 2023Ch S S S MURALIEmployeeSell2.0K₹18.4L910.002.0K → —0.00%7(2)told 4 Oct 2023
4 Oct 2023GITA RAOEmployeeSell1.8K₹16.3L907.314.1K → 2.3K0.00%0.00 pp7(2)told 3 Oct 2023
4 Oct 2023Venugopalan MuralidharanEmployeeSell6.0K₹55.7L927.7360.8K → 54.8K0.01%-0.00 pp7(2)told 30 Sept 2023
21 Sept 2023V SUBBA RAOEmployeeSell3.0K₹27.0L899.003.2K → 2260.00%0.00 pp7(2)told 20 Sept 2023
15 Sept 2023SALGUNAN KCEmployeeSell1.7K₹15.3L898.053.3K → 1.6K0.00%0.00 pp7(2)told 14 Sept 2023
13 Sept 2023NAGA PRASAD VISHNUBHOTLAEmployeeSell5.0K₹43.3L865.119.3K → 4.3K0.00%0.00 pp7(2)told 12 Sept 2023
4 Sept 2023T.V.SrinivasOtherSell4.0K₹33.0L825.675.0K → 1.0K0.00%0.00 pp7(2)told 31 Aug 2023
30 Jun 2023RAMU GUNTUPALLIEmployeeSell2.3K₹16.3L726.142.3K → —0.00%7(2)told 28 Jun 2023
5 Apr 2023SRINIVASA RAO KARIMIKONDAEmployeeSell2.5K₹13.0L518.582.5K → —0.00%7(2)told 3 Apr 2023
13 Mar 2023K NAGARAJUOtherBuy7.0K₹32.4L462.287.8K → 14.8K0.00%0.00 pp7(2)told 10 Mar 2023
15 Sept 2022YUGANDHAR PUVVALAEmployeeSell20.0K₹1.1Cr550.5020.0K → —0.00%7(2)told 14 Sept 2022
1 Sept 2022YUGANDHAR PUVVALAEmployeeSell5.0K₹27.5L550.0025.0K → 20.0K0.00%0.00 pp7(2)told 30 Aug 2022
22 Feb 2022G. MADHAVA RAM PRASADEmployeeSell3.7K₹24.5L652.529.0K → 5.3K0.00%0.00 pp7(2)told 19 Feb 2022
1 Jan 2022AMARNATH GOVULAEmployeeSell1.4K₹10.6L730.931.4K → —0.00%7(2)told 1 Jan 2022
1 Jan 2022ARUNA RANI VAVILALAEmployeeSell1.4K₹10.6L730.521.5K → 430.00%0.00 pp7(2)told 31 Dec 2021
1 Jan 2022RAHUL MANORANJANEmployeeSell1.6K₹11.7L739.001.6K → —0.00%7(2)told 31 Dec 2021
30 Dec 2021VEERA VENKATA RAVINDRA NAGESWARA RAOEmployeeSell2.1K₹15.5L721.002.6K → 4980.00%0.00 pp7(2)told 29 Dec 2021
23 Dec 2021NAVIN NARAINDAS THADANIEmployeeSell3.0K₹21.0L700.003.0K → —0.00%7(2)told 22 Dec 2021

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 16 Oct 2025

CSV
12 of 61 deals
By year
DateDealClientQuantityPriceValue
16 Oct 2025Sell · blockGOLDMAN SACHS (SINGAPORE) PTE.- ODI1.06L1,107.00₹11.8Cr
16 Oct 2025Buy · blockGOLDMAN SACHS BANK EUROPESE - ODI1.06L1,107.00₹11.8Cr
25 Jan 2024Sell · blockSOCIETE GENERALE1.08L1,160.10₹12.5Cr
25 Jan 2024Buy · blockMARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND53.6K1,160.10₹6.2Cr
25 Jan 2024Buy · blockMARSHALL WACE INVESTMENT STRATEGIES TOPS FUND44.9K1,160.10₹5.2Cr
25 Jan 2024Buy · blockMARSHALL WACE INVESTMENT STRATEGIES MARKET NEUTRAL TOPS FUND8.1K1,160.10₹94.4L
25 Jan 2024Buy · blockMARSHALL WACE INVESTMENT STRATEGIES SYSTEMATIC ALPHA PLUS FUND8621,160.10₹10.0L
14 Nov 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO2.97L489.30₹14.5Cr
14 Nov 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF2.97L489.30₹14.5Cr
3 Nov 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO2.97L557.30₹16.6Cr
3 Nov 2022Buy · blockISHARES CORE MSCI EMERGING MARKETS ETF2.97L557.30₹16.6Cr
3 Oct 2022Sell · blockISHARES CORE EMERGING MARKETS MAURITIUS CO3.20L510.60₹16.3Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to AUROPHARMA.

Price band: No band · not in the F&O ban · 38.0% of the market-wide position limit used.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: band changes · ban days · MWPL.

Every stock on this session →

Futures & options · 20 Nov 2026

CSV

Short buildup — price down as fresh positions opened — new shorts.

Futures OI
1.45Cr

₹2,617.0Cr

OI change
+0.14%
Basis
-0.07%
Rollover
85.3%
PCR (OI)
0.70
PCR (volume)
0.58
Front settle
1,797.70
Lot size
550

shares

Futures volume
11.4K

contracts

Futures trades
7,936
Futures value
₹1,138.8Cr
Sessions shown
250

Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.

Option chain · 20 Nov 2026 · lot 550

Put OICall OI
Max pain
1,720

-4.4% from spot

Call OI wall
1,800
Put OI wall
1,700
PCR (OI, this expiry)
0.65
PutsStrikeCalls
1,560
1,580
1,600
1,620
1,640
1,660
1,680
1,700PW
1,720MP
1,740
1,760
1,780
Spot 1,798.99
1,800CW
1,820
1,840
1,860
1,880
1,900
1,920
1,940
1,960
1,980
2,000
2,020
2,040

1,720: puts 1.64L OI (−12.1K), close 0.20, ₹14.3Cr notional in 117 trades · calls 1.41L OI (−1.1K), close 89.00, ₹49.7L notional in 5 trades

Open interest in shares on the 20 Nov 2026 session, around the cash price. MP is max pain, the strike where option holders would collect least at expiry; CW and PW are the strikes above and below the price with the most open calls and puts. On expiry day the front is already the next expiry. Scan them with max_pain, call_oi_wall and put_oi_wall.

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue from operations7,351.87,580.27,567.07,796.17,978.58,382.17,868.18,285.78,645.98,853.39,150.410,263.3
Other income162.5135.6220.9136.0157.3134.8105.3120.6187.6117.0264.2168.2
Total income7,514.37,715.87,788.07,932.18,135.88,516.97,973.48,406.38,833.58,970.49,414.610,431.5
Total expenses6,249.36,351.16,462.76,724.96,937.67,149.76,768.67,132.07,430.17,677.37,857.88,740.9
└ Finance costs75.689.4111.0112.7118.5115.097.895.292.898.2101.7102.2
└ Depreciation423.3354.3404.2382.3418.5444.4405.7429.2464.7478.6486.8531.2
Profit before tax1,265.01,242.61,325.31,207.21,198.31,367.31,204.91,274.31,338.21,293.01,516.61,690.6
Tax expense322.5322.6405.7390.5354.3432.3382.6427.8428.7369.8483.1563.8
Net profit940.0907.4918.2817.0845.6902.8824.2848.1909.8920.81,032.01,123.8
EPS16.0415.5115.6914.0014.5615.5614.2014.6115.6715.8617.8619.57
Net margin12.79%11.97%12.13%10.48%10.60%10.77%10.48%10.24%10.52%10.40%11.28%10.95%
PBT margin17.21%16.39%17.51%15.48%15.02%16.31%15.31%15.38%15.48%14.61%16.57%16.47%
Tax rate25.49%25.96%30.61%32.35%29.57%31.61%31.75%33.57%32.04%28.60%31.85%33.35%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 4 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets39,890.043,923.645,071.548,094.549,785.052,545.658,502.261,754.3
Current assets21,545.723,552.223,771.926,225.627,162.528,648.732,708.833,958.7
└ Cash & equivalents4,396.34,132.13,393.53,904.05,569.05,401.67,191.46,231.5
└ Other bank balances1,687.92,939.52,884.82,935.72,666.53,489.82,678.93,717.8
└ Current investments151.077.550.628.50.01.0747.228.7
└ Trade receivables4,466.44,639.64,816.75,388.35,745.95,891.17,094.47,543.5
└ Inventories8,511.29,282.39,808.210,431.910,543.711,191.912,052.913,124.4
Total equity26,851.928,194.529,850.830,885.032,646.935,033.937,882.839,398.0
└ Attributable to owners26,839.928,188.829,842.830,878.432,653.335,041.137,891.039,399.9
└ Non-controlling interest12.05.78.06.6(6.4)(7.3)(8.2)(1.9)
└ Share capital58.658.658.658.158.158.158.157.5
Borrowings4,861.56,245.36,315.28,090.97,941.77,478.97,676.28,233.8
└ Current4,242.64,537.14,180.36,142.96,380.06,440.46,873.57,251.8
└ Non-current619.01,708.32,134.91,948.01,561.71,038.5802.8981.9
Trade payables3,871.34,505.44,454.24,433.14,188.94,750.65,567.35,892.4
Current liabilities11,493.813,012.012,199.114,340.614,682.315,500.818,039.019,667.2
Total liabilities13,038.115,729.115,220.717,209.517,138.017,511.720,619.322,356.3
Net debt(1,373.7)(903.7)(13.7)1,222.6(293.8)(1,413.5)(2,941.3)(1,744.2)
Debt / equity0.180.220.210.260.240.210.200.21
Current ratio1.871.811.951.831.851.851.811.73

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow2,386.81,500.32,434.5652.43,924.62,885.15,526.43,283.1
└ Capex(2,720.4)(2,078.9)(3,561.5)(880.1)(2,519.6)(1,576.7)(3,104.7)(1,655.2)
Free cash flow(333.7)(578.6)(1,127.0)(227.7)1,405.11,308.42,421.71,628.0
Investing cash flow(3,977.8)(3,061.3)(4,256.0)(707.6)(1,875.1)(2,223.4)(3,458.4)(3,702.2)
Financing cash flow1,814.41,292.6800.4545.2119.8(942.6)(1,269.2)(595.7)
└ Dividends paid(439.5)(0.1)(263.6)(0.7)0.0(232.2)(232.4)(0.0)
└ Buybacks0.00.00.0(930.2)(930.2)0.00.0(805.8)
Net change in cash223.4(263.4)(1,006.8)510.92,178.4(280.9)798.8(970.0)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

AUROPHARMA at a glance

  • AUROPHARMA closed at ₹1,799 on 20 Nov 2026, -0.37% on the day, +47.2% over one year, 3.3% below its 52-week high of ₹1,859.9.
  • Delivery was 61.6% of traded quantity on 20 Nov 2026, the 98th percentile of its own 3,629 sessions with a reading (20-session average 53.6%, 1-year average 48.5%).
  • Market capitalisation is ₹1.04 lakh crore at a trailing P/E of 25.9 (trailing EPS ₹69.35).
  • Q2 FY27 results (consolidated, filed 4 Nov 2026): revenue ₹10,263 crore (+23.9% year on year), net profit ₹1,124 crore (+32.5%); the price moved +4.7% on the first session after.
  • Promoters held 51.88% at 30 Sept 2026, unchanged on the previous filing, with 11.99% of promoter shares pledged.
  • Q3 FY27 results are expected between 6 Feb 2027 and 10 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE406A01037
SeriesEQ
Listed19 Jul 2000
NSE market cap · 17 Nov 2026₹1.03L Cr
Free-float market cap (NSE)₹49,450 Cr
Shares outstanding (NSE)57.54Cr
History from19 Oct 1995
Sessions7,608
Turnover rank#125

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.